Johnson & Johnson's 2013 Device Sales Up 4% From 2012

Johnson & Johnson announced its fourth quarter and year-end financials, and its medical device and diagnostic sales increased 3.9 percent from 2012. Total global 2013 sales totaled $28.5 million, up from 2012's $27.4 million. Fourth quarter device sales, which totaled $7.3 million, dropped 1 percent compared to the same period last year.

Year-end orthopedic device sales reached $9.5 million, up nearly 22 percent from 2012's $7.7 million in sales.

The company's net income for 2013 was $13.8 billion, up from $10.5 billion in 2012.

More Articles on Devices:
Titan Spine Gains 5 Patents for Endoskeleton Interbody Devices
Budgetary Fund Could Pay to Eliminate Medical Device Tax
Intellirod Spine Secures $1.6M Loan From Ohio Third Frontier